Category: Hospitalizations

Ventilator-associated pneumonia in ICU patients with severe pneumonia and respiratory failure

Posted on | Posted on John Murphy | Leave a Comment on Ventilator-associated pneumonia in ICU patients with severe pneumonia and respiratory failure

Sarah Jackson Published June 15, 2023 – 10.1172/JCI172643 The Journal of Clinical Medicine The COVID-19 pandemic resulted in an unprecedented number of patients hospitalized in intensive care units (ICUs) because of severe SARS-CoV-2 infection (1). Respiratory failure in ICU patients, whether due to respiratory infection or other causes, may necessitate mechanical ventilation if oxygen levels cannot […]

COVID-19 Therapeutics for Nonhospitalized Patients

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 Therapeutics for Nonhospitalized Patients

Rajesh T. Gandhi, MD1; Preeti N. Malani, MD, MSJ2,3; Carlos del Rio, MD4, JAMA. 2022;327(7):617-618. doi:10.1001/jama.2022.0335 Substantial progress has been made in therapeutics for nonhospitalized patients with COVID-19, but supply of and access to treatment remain limited. This Viewpoint summarizes currently available therapeutics for nonhospitalized patients in the setting of the Omicron variant including principles for equitable allocation. Patients with mild or moderate COVID-19 […]

FDA, CDC Hid Data On Spike In COVID Cases Among The Vaccinated: Documents

Posted on | Posted on John Murphy | Leave a Comment on FDA, CDC Hid Data On Spike In COVID Cases Among The Vaccinated: Documents

SEP 2023 – Authored by Zachary Stieber The Epoch Times COVID-19 cases among vaccinated seniors soared in 2021, according to newly disclosed data that was acquired by U.S. health agencies but not presented to the public. Syringes and vials of the Pfizer-BioNTech COVID-19 vaccine are prepared to be administered at a drive-up vaccination site from […]

Hydroxychloroquine Associated With Lower COVID-19 Mortality: Study

Posted on | Posted on John Murphy | Leave a Comment on Hydroxychloroquine Associated With Lower COVID-19 Mortality: Study

The French study included 30,202 patients. Zachary Stieber, 11/3/2023 Epoch Health People who received hydroxychloroquine were less likely to die than those who did not, according to a new study. Just 0.8 percent of patients at a facility in France who received hydroxychloroquine (HCQ) and an antibiotic died, compared to 4.8 percent of patients who did […]

Study Deems Popular COVID Treatment ‘Ineffective,’ Sometimes ‘Harmful’

Posted on | Posted on John Murphy | Leave a Comment on Study Deems Popular COVID Treatment ‘Ineffective,’ Sometimes ‘Harmful’

The often debated treatment did not improve outcomes in critically ill patients Published 10/27/23, Hannah Murphy, The Messenger High doses of intravenous vitamin C are no more effective than a placebo when it comes to treating patients hospitalized with severe COVID-19 infections, a new study shows. Published in JAMA, the study compared treatment regimens and their resultant […]

Incidence of New-Onset Hypertension Post–COVID-19: Comparison With Influenza

Posted on | Posted on John Murphy | Leave a Comment on Incidence of New-Onset Hypertension Post–COVID-19: Comparison With Influenza

Vincent Zhang, Molly Fisher,Wei Hou,Lili Zhang and Tim Q. Duong    Aug 2023 https://doi.org/10.1161/HYPERTENSIONAHA.123.21174 Hypertension. 2023;0 Abstract BACKGROUND: SARS-CoV-2 may trigger new-onset persistent hypertension. This study investigated the incidence and risk factors associated with new-onset persistent hypertension during COVID-19 hospitalization and at ≈6-month follow-up compared with influenza. METHODS: This retrospective observational study was conducted in a major academic […]

COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside

David Sulzer, Angelo Antonini, Valentina Leta, Anna Nordvig, Richard J. Smeyne, James E. Goldman, Osama Al-Dalahmah, Luigi Zecca, Alessandro Sette, Luigi Bubacco, Olimpia Meucci, Elena Moro, Ashley S. Harms, Yaqian Xu, Stanley Fahn & K. Ray Chaudhuri  npj Parkinson’s Disease volume 6, Article number: 18 (2020) Cite this article Abstract This Viewpoint discusses insights from basic science and clinical perspectives on coronavirus disease 2019 (COVID-19)/severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection in the brain, with a particular focus […]

What you need to know about Covid as new variant rises

Posted on | Posted on John Murphy | Leave a Comment on What you need to know about Covid as new variant rises

September 24, 2023 BBC News Jim Reed The number of people in hospital has gone up. Google searches have doubled in a month and booster vaccines have been brought forward because of a new variant. It might all feel a bit 2021. But – these days – how much do we really need to worry […]

COVID Surge Turns Into Trickle As Hospital Admissions Wane

Posted on | Posted on John Murphy | Leave a Comment on COVID Surge Turns Into Trickle As Hospital Admissions Wane

SEP 29, 2023 – 07:20 AM Authored by Jack Phillips via The Epoch Times  After multiple weeks of increasing COVID-19 hospital admissions, federal data show that the figure is now falling. In the week ending Sept. 16, U.S. Centers for Disease Control and Prevention (CDC) data show hospitalizations are down 4.3 percent. The number had been increasing […]

Paxlovid Is Now Less Effective Against Covid, Study Shows

Posted on | Posted on John Murphy | Leave a Comment on Paxlovid Is Now Less Effective Against Covid, Study Shows

Story by Nacha Cattan  Sept 21, 2023 Bloomberg A fourth dose of the Pfizer-BioNTech vaccine was insufficient to prevent infection with the omicron variant of Covid-19, according to preliminary data from a trial in Israel released Monday.© Bloomberg (Bloomberg) — In a real-world study of people with Covid-19, Pfizer Inc.’s antiviral Paxlovid was less effective at […]